| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.06.07 | Prophylaktische Behandlung von Patienten nach einer Transplantation mit Defibrotide kann Todesfälle durch die Venenverschlusskrankheit reduzieren | 415 | Business Wire | Gentium S.p.A. (Nasdaq: GENT) hat die Veröffentlichung der Ergebnisse
einer unabhängigen klinischen Studie bekannt gegeben, die die
prophylaktische Behandlung... ► Artikel lesen | |
| 02.06.07 | Amata Inc. to Provide State-of-the-Art Security System for Pacific Texas Pipeline & Transportation Company | 74 | Business Wire | Amata Inc., a leading edge provider of installation services for the
national and international security sectors, today announced its $152M
contract with Pacific... ► Artikel lesen | |
| 02.06.07 | Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer | 73 | PR Newswire | CHICAGO, June 2 /PRNewswire/ --
- Study Highlights Quality-of-Life Data
ALIMTA(R) (pemetrexed for injection) showed additional utility in the
treatment of the most diagnosed type of... ► Artikel lesen | |
| 02.06.07 | Pharmion and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting | 59 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Pharmion Corporation and MethylGene Inc. (TSX: MYG) today announced preliminary Phase II and Phase I/II data for their lead oncology product candidate, MGCD0103... ► Artikel lesen | |
| 02.06.07 | New Data Show Bondronat(R) Prevents Bone Loss Caused by anastrozole in Women With Surgically Treated Breast Cancer | 491 | news aktuell | Chicago, Illinois (ots/PRNewswire) - - One Year Results From the ARIBON Study Presented at ASCO 2007 Bondronat(R) (ibandronic acid) has been shown to prevent bone loss caused by anastrozole in post-menopausal... ► Artikel lesen | |
| 02.06.07 | Glaxo's pazopanib shows activity in ovarian cancer | 75 | AFX News | LONDON (Thomson Financial) - GlaxoSmithKline PLC said biological activity was seen in 41 pct of patients in a phase II trial of pazopanib in patients with cancer of the ovaries, fallopian tube... ► Artikel lesen | |
| 02.06.07 | Bid for Journal is talk of Wall Street | 116 | AFX News | NEW YORK (AP) - Financial analyst Edouard Morin slid from his lunch seat at the swanky Harry's Cafe around the corner from Wall Street and sized up the latest merger talk... ► Artikel lesen | |
| 02.06.07 | Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer | 25 | PR Newswire | CHICAGO, June 2 /PRNewswire/ --
- Five Phase III Early-Stage Breast Cancer Studies Underway With GEMZAR
GEMZAR(R) (gemcitabine HC1 for injection), approved in combination with
paclitaxel... ► Artikel lesen | |
| 02.06.07 | Genomic Health, Inc. Announces Oncotype DX Recurrence Score Influences Treatment Decisions for Physicians and Patients in Prospective Study | 29 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced results of an independent prospective multi-center study indicating that the Oncotype DX Recurrence Score changes treatment... ► Artikel lesen | |
| 02.06.07 | Study Presented at ASCO Shows Encouraging Preliminary Results for Phase II Trial of OGX-011 in Advanced Prostate Cancer | 41 | PR Newswire | VANCOUVER and CARLSBAD, CA, June 2 /PRNewswire-FirstCall/ -- OncoGenex Technologies Inc. and Isis Pharmaceuticals, Inc. today announced preliminary data from a Phase II clinical trial of OGX-011 in... ► Artikel lesen | |
| 02.06.07 | Clinical Data Presented on Pilot Pharmacokinetic Study of Oral Azacitidine | 181 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Pharmion Corporation today reported data from a pilot study that demonstrated the bioavailability of the Company's oral dosage formulation of Azacitidine.... ► Artikel lesen | |
| 02.06.07 | Donnerwetter.de/Meldung: Blitzschäden und Versicherungen | 444 | Dow Jones News | In den letzten Tagen gab es zahlreiche Gewitter in Deutschland. Tausende Blitze verursachten Schäden in Millionenhöhe und in den nächsten Tagen muss mit weiteren Gewittern gerechnet werden. Privatleute... ► Artikel lesen | |
| 02.06.07 | Avastin(R) Significantly Prolongs Progression Free Survival in Advanced Kidney Cancer | 28 | news aktuell | Chicago (ots/PRNewswire) - - Patients Have a Chance to Live Almost Twice as Long Without Their Disease Returning Adding Avastin (bevacizumab) to interferon offers patients with advanced renal cell... ► Artikel lesen | |
| 02.06.07 | Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer | 33 | Business Wire | Genentech, Inc. (NYSE:DNA) today announced that a Roche-sponsored,
randomized placebo-controlled Phase III clinical study of Avastin®
(bevacizumab) in combination... ► Artikel lesen | |
| 02.06.07 | Results of VEGF Trap (Aflibercept) Highlighted at ASCO 2007 Annual Meeting | 29 | Business Wire | ABSTRACT # 5508
ABSTRACT # 7627
Sanofi-Aventis (Euronext: SAN and NYSE: SNY) and Regeneron
Pharmaceuticals, Inc. (Nasdaq: REGN) today... ► Artikel lesen | |
| 02.06.07 | Results of VEGF Trap (Aflibercept) Highlighted at ASCO 2007 Annual Meeting | 25 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. today announced encouraging preliminary results from two Phase II studies... ► Artikel lesen | |
| 02.06.07 | Crest Toothpaste Safe | 25 | PR Newswire | CINCINNATI, June 2 /PRNewswire-FirstCall/ -- The Procter & Gamble Company's Crest toothpaste brand is not affected by the FDA import and health alert. Crest does not import toothpaste manufactured... ► Artikel lesen | |
| 02.06.07 | -- ABSCHLUSSBERICHT -- LinuxTag in Berlin angekommen - 9.600 Besucher bei Europas führender Kongressmesse für Freie Software | 80 | news aktuell | Berlin (ots) - LinuxTag in Berlin angekommen - 9.600 Besucher bei Europas führender Kongressmesse für Freie Software LinuxTag e.V. und Messe Berlin vereinbaren langfristige Zusammenarbeit - Nächster... ► Artikel lesen | |
| 02.06.07 | Der Tagesspiegel: Nach starkem Start erwartet Industrie gutes Eisjahr - und kündigt Preiserhöhungen an | 81 | news aktuell | Berlin (ots) - Das wilde Mai-Wetter hat der Eisindustrie die Laune nicht verderben können. "Nach dem frühen und guten Start mit Superwetter im April sind wir optimistisch, dass es ein gutes Eisjahr... ► Artikel lesen | |
| 02.06.07 | Cyclacel Reports Phase I Sapacitabine Data in Patients with Advanced Leukemias and Myelodysplastic Syndromes at 2007 ASCO Annual Meeting | 39 | Business Wire | Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) reported
interim results from a Phase I clinical trial of sapacitabine (CYC682),
a novel orally available... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.637 |
| BAYER | 1.396 |
| NEL | 1.316 |
| TUI | 1.178 |
| PLUG POWER | 1.144 |
| NOVAVAX | 1.130 |
| SIEMENS ENERGY | 1.098 |
| MERCEDES-BENZ | 1.074 |
| PALANTIR TECHNOLOGIES | 758 |
| ALLIANZ | 718 |
| NVIDIA | 716 |
| RWE | 677 |
| DEUTSCHE BANK | 661 |
| BYD | 621 |
| BASF | 575 |
| DEUTSCHE LUFTHANSA | 573 |
| RHEINMETALL | 539 |
| TESLA | 526 |
| VOLKSWAGEN | 509 |
| INFINEON | 493 |
| COMMERZBANK | 485 |
| AIXTRON SE | 470 |
| NORDEX | 468 |
| STANDARD LITHIUM | 450 |
| RENK GROUP | 448 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
